This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors
Scientific Reports Open Access 01 June 2017
-
Bispecific antibodies and their applications
Journal of Hematology & Oncology Open Access 21 December 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Williams, S. Small nanobody drugs win big backing from pharma. Nat Med 19, 1355–1356 (2013). https://doi.org/10.1038/nm1113-1355
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1113-1355
This article is cited by
-
Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors
Scientific Reports (2017)
-
A synthetic library for rapid isolation of humanized single-domain antibodies
Biotechnology and Bioprocess Engineering (2017)
-
Bispecific antibodies and their applications
Journal of Hematology & Oncology (2015)
-
Chaperone Nanobodies Protect Gelsolin Against MT1-MMP Degradation and Alleviate Amyloid Burden in the Gelsolin Amyloidosis Mouse Model
Molecular Therapy (2014)